Royalty Pharma Plc (RPRX) — Financial Flexibility Index
Royalty Pharma Plc (RPRX) has a Financial Flexibility Index of 0.08x as of March 2026. Free cash flow of $760.54 Million (operating CF $760.54 Million minus capex $0.00) represents 0% of total liabilities ($9.88 Billion). Check RPRX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Royalty Pharma Plc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Royalty Pharma Plc across 14 annual periods. See Royalty Pharma Plc (RPRX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Royalty Pharma Plc (2002–2025)
Year-by-year free cash flow to debt coverage for Royalty Pharma Plc. For the full company profile including market capitalisation, see RPRX market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | $2.49 Billion | $2.49 Billion | $9.91 Billion | ▼ -28.5% |
| 2024 | 0.35x | $2.77 Billion | $2.77 Billion | $7.88 Billion | ▼ -56.6% |
| 2023 | 0.81x | $5.10 Billion | $2.99 Billion | $6.30 Billion | ▲ +41.1% |
| 2022 | 0.57x | $4.19 Billion | $2.14 Billion | $7.29 Billion | ▲ +106.8% |
| 2021 | 0.28x | $2.02 Billion | $2.02 Billion | $7.27 Billion | ▼ -59.8% |
| 2020 | 0.69x | $4.23 Billion | $2.03 Billion | $6.12 Billion | ▲ +28.6% |
| 2019 | 0.54x | $3.39 Billion | $1.67 Billion | $6.31 Billion | ▲ +94.0% |
| 2018 | 0.28x | $1.89 Billion | $1.62 Billion | $6.82 Billion | ▼ -48.5% |
| 2017 | 0.54x | $3.71 Billion | $1.42 Billion | $6.90 Billion | ▲ +20862.9% |
| 2016 | 0.00x | $-15.58 Million | $-15.58 Million | $6.02 Billion | ▲ +37.5% |
| 2015 | 0.00x | $-25.33 Million | $-25.33 Million | $6.12 Billion | ▲ +100.0% |
| 2014 | -10.03x | $-29.33 Million | $-29.33 Million | $2.92 Million | ▼ -148.7% |
| 2003 | 20.61x | $11.15 Million | $11.15 Million | $541.00K | ▲ +25.9% |
| 2002 | 16.37x | $8.49 Million | $8.45 Million | $519.00K | — |